Demegen-Pacgen licensing deal announced

03/23/2005 | American City Business Journals

Pennsylvania-based Demegen said it licensed certain peptides to Pacgen Biopharmaceuticals, a Vancouver, British Columbia, firm specializing in drug design and development for infectious diseases and immune system regulations. Pacgen's CEO said the move would help his firm move products to the market more quickly.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC